Documente Academic
Documente Profesional
Documente Cultură
1 Case No.
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 2 of 46 Page ID #:2
1 Case No.
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 3 of 46 Page ID #:3
67894037v2 2
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 4 of 46 Page ID #:4
67894037v2 3
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 5 of 46 Page ID #:5
1 and is prima facie proof that the design shown in the ‘714 Patent is novel and non-
2 obvious.
3
4
5
6 Fig. 2
7 15. Theragun is the owner of United States Patent Number D880,715,
8 entitled “Percussive Massage Device” (hereinafter the “ ‘715 Patent”), issued on April
9 7, 2020, a true and correct copy of which is attached hereto as Exhibit C. The ‘715
10 Patent pertains to a particular ornamental design for a therapeutic percussive massage
11 device, including as depicted in Fig. 3 below. The ‘715 Patent is presumed to be valid
12 and is prima facie proof that the design shown in the ‘715 Patent is novel and non-
13 obvious.
14
15
16
17 Fig. 3
18 16. Theragun is the owner of United States Patent Number D880,716,
19 entitled “Percussive Massage Device” (hereinafter the “ ‘716 Patent”), issued on April
20 7, 2020, a true and correct copy of which is attached hereto as Exhibit D. The ‘716
21 Patent pertains to a particular ornamental design for a therapeutic percussive massage
22 device, including as depicted in Fig. 4 below. The ‘716 Patent is presumed to be valid
23 and is prima facie proof that the design shown in the ‘716 Patent is novel and non-
24 obvious.
25
26
27
28 Fig. 4
67894037v2 4
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 6 of 46 Page ID #:6
67894037v2 5
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 7 of 46 Page ID #:7
1 is presumed to be valid and is prima facie proof that the design shown in the ‘387
2 Patent is novel and non-obvious.
3
4
5 Fig. 7
6 20. Theragun is the owner of United States Patent Number D849,260,
7 entitled “Massage Element” (hereinafter the “ ‘260 Patent”), issued on May 21, 2019,
8 a true and correct copy of which is attached hereto as Exhibit H. The ‘260 Patent
9 pertains to a particular ornamental design for an attachment for percussive massage
10 devices, including as depicted in Fig. 8 below. The ‘260 Patent is presumed to be valid
11 and is prima facie proof that the design shown in the ‘260 Patent is novel and non-
12 obvious.
13
14
15 Fig. 8
16 21. Theragun is the owner of United States Patent Number D849,261,
17 entitled “Massage Element” (hereinafter the “ ‘261 Patent”), issued on May 21, 2019,
18 a true and correct copy of which is attached hereto as Exhibit I. The ‘261 Patent
19 pertains to a particular ornamental design for an attachment for percussive massage
20 devices, including as depicted in Fig. 9 below. The ‘261 Patent is presumed to be valid
21 and is prima facie proof that the design shown in the ‘261 Patent is novel and non-
22 obvious.
23
24
25 Fig. 9
26 22. Theragun is the owner of United States Patent Number D861,182,
27 entitled “Massage Element” (hereinafter the “ ‘182 Patent”), issued on September 24,
28 2019, a true and correct copy of which is attached hereto as Exhibit J. The ‘182 Patent
67894037v2 6
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 8 of 46 Page ID #:8
1 25. The ‘387 Patent, ‘714 Patent, ‘715 Patent, ‘716 Patent, ‘985 Patent, ‘986
2 Patent, ‘260 Patent, ‘351 Patent, ‘261 Patent, 182 Patent, the ‘640 Patent, and ‘680
3 Patent are referred to herein collectively as the “Patents” and individually as a
4 “Patent.” A number of the Patents issued to Theragun, LLC, which entity has been
5 converted to Theragun, Inc., plaintiff herein. Theragun is the current owner of each
6 of the Patents.
7 26. Theragun owns the federally registered trademark THERAGUN, which
8 trademark is the subject of U.S. Reg. No. 5,213,141, and which mark it has used the
9 since at least as early as May 31, 2015.
10 27. Additionally, since at least as early as May 31, 2015, Theragun has used
11 a distinctive blue color in presenting its trademarks, in its marketing and advertising,
12 and on its massage gun products and their packaging. Images of examples of this
13 usage are shown below in Fig. 13.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28 Fig. 13
67894037v2 8
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 10 of 46 Page ID #:10
67894037v2 9
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 11 of 46 Page ID #:11
67894037v2 10
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 12 of 46 Page ID #:12
1
2
3
4
5
6
Fig. 19 (the “CRG-04” with attachment)
7
8
9
10
11
12
13
14 Fig. 20 (the “CRG-01” with battery)
35. Dezhou sells its infringing products under the brand name CRIFIT.
15
Theragun is informed and believes and, based thereon, alleges that Dezhou sells or
16
manufactures infringing products to or for distributors and resellers in the United
17
States, including, without limitation, the other Defendants herein, who in turn import,
18
sell, offer to sell, the infringing Dezhou products. In fact, Dezhou advertises that it
19
can place alternative brand names on its products and packaging and provide sample
20
products within three days.
21
36. Defendants’ infringing products are virtually identical to Theragun’s
22
patented products, as can be seen in the product images above. In addition, numerous
23
Defendants are using a virtually identical blue color on their massage gun products
24
and are using the same color in many of their packaging and marketing materials.
25
Indeed, these Defendants have applied the blue color to their products in virtually the
26
same locations and positions as that blue color is applied to the Theragun products.
27
28
67894037v2 11
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 13 of 46 Page ID #:13
1 37. Not only has Dezhou created virtual copies of Theragun’s patented
2 products, and not only has Dezhou applied the same blue color to these copies, but
3 Dezhou is also using Theragun’s federally registered trademark THERAGUN as part
4 of its product name in listings on Alibaba.com. As a result, when a search is conducted
5 on Alibaba.com for “Theragun”, the first result is one of Dezhou’s knock-offs, bearing
6 THERAGUN as part of its name.
7 38. Defendants’ application of the same blue color to their virtually identical
8 products in virtually the same location and the same positions as that blue color is
9 applied to the Theragun products is likely to cause confusion or mistake, or to deceive
10 members of the public into believing that Defendants’ massage gun products are
11 approved, sponsored, endorsed, or licensed by, or affiliated, connected or otherwise
12 associated with Theragun, which is not the case. Such confusion, mistake, or
13 deception will inevitably continue after the sale of the products, as consumers
14 continue to encounter Defendants’ infringing products at gyms, in therapists or
15 doctors’ offices, or in other post-sale contexts, and as a result of such post-sale
16 confusion the harm to Theragun’s reputation will continue and be amplified.
17 39. The potential for confusion is amplified and exacerbated by Dezhou’s
18 use of the THERAGUN mark in its product listings on alibaba.com, and Dezhou’s
19 use of the THERAGUN is likely to cause confusion or mistake, or to deceive members
20 of the public into believing that Defendants’ massage gun products are approved,
21 sponsored, endorsed, or licensed by, or affiliated, connected or otherwise associated
22 with Theragun, which is not the case.
23 FIRST CAUSE OF ACTION
24 Federal Trademark Infringement, 15 U.S.C. § 1114
25 (Against Dezhou)
26 40. Theragun realleges and incorporates by reference all foregoing
27 paragraphs as if fully set forth herein.
28
67894037v2 12
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 14 of 46 Page ID #:14
67894037v2 13
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 15 of 46 Page ID #:15
67894037v2 14
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 16 of 46 Page ID #:16
67894037v2 15
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 17 of 46 Page ID #:17
67894037v2 16
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 18 of 46 Page ID #:18
67894037v2 17
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 19 of 46 Page ID #:19
1 72. At all times herein mentioned the ‘351 Patent was and is valid and fully
2 enforceable.
3 73. Defendants are offering percussive massage devices that infringe the
4 ‘351 Patent, including at least the Recovery Pro, Recovery Volt, CRG-02, and CRG-
5 03, as shown in Figs. 14-17, above. As shown below, a side by side comparison of
6 Theragun’s ‘351 Patent and Defendants’ Infringing Devices quickly reveals that the
7 Infringing Devices appear substantially the same as Theragun’s ‘351 Patent to an
8 ordinary observer; the resemblance is such as to deceive such an observer, inducing
9 him or her to purchase one supposing it to be the other:
10
11
12
13
14 ‘351 Patent
15
16
17
18
19
Recovery Pro Recovery Volt
20
21
22
23
24
25 CRG-03 CRG-02
26 74. By the acts complained of herein, Defendants have been and are
27 presently infringing the ‘351 Patent by actively and knowingly: (i) importing, making,
28 using, selling and/or offering to sell products incorporating the design of the ‘351
67894037v2 18
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 20 of 46 Page ID #:20
1 Patent, including the above-identified devices; (ii) inducing others to infringe the ‘351
2 Patent by inducing others to import, sell, offer for sale, and/or use products
3 incorporating the design of the ‘351 Patent, including the above-identified devices;
4 and/or (iii) contributing to the infringement of the ‘351 Patent.
5 75. Defendants’ infringe literally or under the doctrine of equivalents, or
6 both.
7 76. At no time has Theragun granted Defendants authorization, license, or
8 permission to utilize the design claimed in the ‘351 Patent.
9 77. Theragun has been damaged by Defendants’ acts of infringement of the
10 ‘351 Patent and Theragun will continue to be damaged by such infringement unless
11 enjoined by this Court. Theragun is entitled to recover damages adequate to
12 compensate for the infringement under 35 U.S.C. § 284.
13 78. Theragun is, and has been, irreparably harmed by Defendants’ on-going
14 infringement including the following harm which cannot be quantified or recouped
15 through monetary damages: (1) lost market share that will be difficult, if not
16 impossible, to recoup later as the Infringing Devices become entrenched with retail
17 sellers and trainers who recommend them to their clients, (2) loss of first mover
18 advantage that Theragun enjoyed as the first company to offer its innovative
19 percussive devices and patented attachments, (3) loss of Theragun’s investment in
20 developing the market for percussive devices and its patented attachments,
21 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
22 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
23 Devices being sold at a price point lower than Theragun’s patented products,
24 (7) diversion of resources to defend against loss of market share caused by sales of
25 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
26 to offer for sale and sell infringing attachments that leads to additional irreparable
27 harm described above.
28
67894037v2 19
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 21 of 46 Page ID #:21
1 79. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 SIXTH CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘714 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 80. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 81. At all times herein mentioned the ‘714 Patent was and is valid and fully
11 enforceable.
12 82. Defendants are offering percussive massage devices that infringe the
13 ‘714 Patent, including at least the CRG-05, as shown in Fig. 18, above. As shown
14 below, a side by side comparison of Theragun’s ‘714 Patent and Defendants’
15 Infringing Devices quickly reveals that the Infringing Devices appear substantially
16 the same as Theragun’s ‘714 Patent to an ordinary observer; the resemblance is such
17 as to deceive such an observer, inducing him or her to purchase one supposing it to
18 be the other:
19
20
21
22
23
24 ‘714 Patent CRG-05
25 83. By the acts complained of herein, Dezhou and Does 1 through 10,
26 inclusive (the “Dezhou Defendants”) have been and are presently infringing the ‘714
27 Patent by actively and knowingly: (i) importing, making, using, selling and/or
28 offering to sell products incorporating the design of the ‘714 Patent, including the
67894037v2 20
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 22 of 46 Page ID #:22
1 above-identified devices; (ii) inducing others to infringe the ‘714 Patent by inducing
2 others to import, sell, offer for sale, and/or use products incorporating the design of
3 the ‘714 Patent, including the above-identified devices; and/or (iii) contributing to the
4 infringement of the ‘714 Patent.
5 84. Defendants’ infringe literally or under the doctrine of equivalents, or
6 both.
7 85. At no time has Theragun granted Defendants authorization, license, or
8 permission to utilize the design claimed in the ‘714 Patent.
9 86. Theragun has been damaged by Defendants’ acts of infringement of the
10 ‘714 Patent and Theragun will continue to be damaged by such infringement unless
11 enjoined by this Court. Theragun is entitled to recover damages adequate to
12 compensate for the infringement under 35 U.S.C. § 284.
13 87. Theragun is, and has been, irreparably harmed by Defendants’ on-going
14 infringement including the following harm which cannot be quantified or recouped
15 through monetary damages: (1) lost market share that will be difficult, if not
16 impossible, to recoup later as the Infringing Devices become entrenched with retail
17 sellers and trainers who recommend them to their clients, (2) loss of first mover
18 advantage that Theragun enjoyed as the first company to offer its innovative
19 percussive devices and patented attachments, (3) loss of Theragun’s investment in
20 developing the market for percussive devices and its patented attachments,
21 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
22 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
23 Devices being sold at a price point lower than Theragun’s patented products,
24 (7) diversion of resources to defend against loss of market share caused by sales of
25 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
26 to offer for sale and sell infringing attachments that leads to additional irreparable
27 harm described above.
28
67894037v2 21
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 23 of 46 Page ID #:23
1 88. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 SEVENTH CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘715 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 89. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 90. At all times herein mentioned the ‘715 Patent was and is valid and fully
11 enforceable.
12 91. Defendants are offering percussive massage devices that infringe the
13 ‘715 Patent, including at least the CRG-05, as shown in Fig. 18, above. As shown
14 below, a side by side comparison of Theragun’s ‘715 Patent and Defendants’
15 Infringing Devices quickly reveals that the Infringing Devices appear substantially
16 the same as Theragun’s ‘715 Patent to an ordinary observer; the resemblance is such
17 as to deceive such an observer, inducing him or her to purchase one supposing it to
18 be the other:
19
20
21
22
23
‘715 Patent
24 CRG-05
25 92. By the acts complained of herein, the Dezhou Defendants have been and
26 are presently infringing the ‘715 Patent by actively and knowingly: (i) importing,
27 making, using, selling and/or offering to sell products incorporating the design of the
28 ‘715 Patent, including the above-identified devices; (ii) inducing others to infringe
67894037v2 22
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 24 of 46 Page ID #:24
1 the ‘715 Patent by inducing others to import, sell, offer for sale, and/or use products
2 incorporating the design of the ‘715 Patent, including the above-identified devices;
3 and/or (iii) contributing to the infringement of the ‘715 Patent.
4 93. Defendants’ infringe literally or under the doctrine of equivalents, or
5 both.
6 94. At no time has Theragun granted Defendants authorization, license, or
7 permission to utilize the design claimed in the ‘715 Patent.
8 95. Theragun has been damaged by Defendants’ acts of infringement of the
9 ‘715 Patent and Theragun will continue to be damaged by such infringement unless
10 enjoined by this Court. Theragun is entitled to recover damages adequate to
11 compensate for the infringement under 35 U.S.C. § 284.
12 96. Theragun is, and has been, irreparably harmed by Defendants’ on-going
13 infringement including the following harm which cannot be quantified or recouped
14 through monetary damages: (1) lost market share that will be difficult, if not
15 impossible, to recoup later as the Infringing Devices become entrenched with retail
16 sellers and trainers who recommend them to their clients, (2) loss of first mover
17 advantage that Theragun enjoyed as the first company to offer its innovative
18 percussive devices and patented attachments, (3) loss of Theragun’s investment in
19 developing the market for percussive devices and its patented attachments,
20 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
21 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
22 Devices being sold at a price point lower than Theragun’s patented products,
23 (7) diversion of resources to defend against loss of market share caused by sales of
24 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
25 to offer for sale and sell infringing attachments that leads to additional irreparable
26 harm described above.
27
28
67894037v2 23
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 25 of 46 Page ID #:25
1 97. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 EIGHTH CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘716 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 98. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 99. At all times herein mentioned the ‘716 Patent was and is valid and fully
11 enforceable.
12 100. Defendants are offering percussive massage devices that infringe the
13 ‘716 Patent, including at least the CRG-05, as shown in Fig. 18, above. As shown
14 below, a side by side comparison of Theragun’s ‘716 Patent and Defendants’
15 Infringing Devices quickly reveals that the Infringing Devices appear substantially
16 the same as Theragun’s ‘716 Patent to an ordinary observer; the resemblance is such
17 as to deceive such an observer, inducing him or her to purchase one supposing it to
18 be the other:
19
20
21
22
23
‘716 Patent
24 CRG-05
25 101. By the acts complained of herein, the Dezhou Defendants have been and
26 are presently infringing the ‘716 Patent by actively and knowingly: (i) importing,
27 making, using, selling and/or offering to sell products incorporating the design of the
28 ‘716 Patent, including the above-identified devices; (ii) inducing others to infringe
67894037v2 24
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 26 of 46 Page ID #:26
1 the ‘716 Patent by inducing others to import, sell, offer for sale, and/or use products
2 incorporating the design of the ‘716 Patent, including the above-identified devices;
3 and/or (iii) contributing to the infringement of the ‘716 Patent.
4 102. Defendants’ infringe literally or under the doctrine of equivalents, or
5 both.
6 103. At no time has Theragun granted Defendants authorization, license, or
7 permission to utilize the design claimed in the ‘716 Patent.
8 104. Theragun has been damaged by Defendants’ acts of infringement of the
9 ‘716 Patent and Theragun will continue to be damaged by such infringement unless
10 enjoined by this Court. Theragun is entitled to recover damages adequate to
11 compensate for the infringement under 35 U.S.C. § 284.
12 105. Theragun is, and has been, irreparably harmed by Defendants’ on-going
13 infringement including the following harm which cannot be quantified or recouped
14 through monetary damages: (1) lost market share that will be difficult, if not
15 impossible, to recoup later as the Infringing Devices become entrenched with retail
16 sellers and trainers who recommend them to their clients, (2) loss of first mover
17 advantage that Theragun enjoyed as the first company to offer its innovative
18 percussive devices and patented attachments, (3) loss of Theragun’s investment in
19 developing the market for percussive devices and its patented attachments,
20 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
21 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
22 Devices being sold at a price point lower than Theragun’s patented products,
23 (7) diversion of resources to defend against loss of market share caused by sales of
24 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
25 to offer for sale and sell infringing attachments that leads to additional irreparable
26 harm described above.
27
28
67894037v2 25
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 27 of 46 Page ID #:27
1 106. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 NINTH CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘985 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 107. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 108. At all times herein mentioned the ‘985 Patent was and is valid and fully
11 enforceable.
12 109. Defendants are offering percussive massage devices that infringe the
13 ‘985 Patent, including at least the CRG-05, as shown in Fig. 18, above. As shown
14 below, a side by side comparison of Theragun’s ‘985 Patent and Defendants’
15 Infringing Devices quickly reveals that the Infringing Devices appear substantially
16 the same as Theragun’s ‘985 Patent to an ordinary observer; the resemblance is such
17 as to deceive such an observer, inducing him or her to purchase one supposing it to
18 be the other:
19
20
21
22
23
24 ‘985 Patent CRG-05
25 110. By the acts complained of herein, the Dezhou Defendants have been and
26 are presently infringing the ‘985 Patent by actively and knowingly: (i) importing,
27 making, using, selling and/or offering to sell products incorporating the design of the
28 ‘985 Patent, including the above-identified devices; (ii) inducing others to infringe
67894037v2 26
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 28 of 46 Page ID #:28
1 the ‘985 Patent by inducing others to import, sell, offer for sale, and/or use products
2 incorporating the design of the ‘985 Patent, including the above-identified devices;
3 and/or (iii) contributing to the infringement of the ‘985 Patent.
4 111. Defendants’ infringe literally or under the doctrine of equivalents, or
5 both.
6 112. At no time has Theragun granted Defendants authorization, license, or
7 permission to utilize the design claimed in the ‘985 Patent.
8 113. Theragun has been damaged by Defendants’ acts of infringement of the
9 ‘985 Patent and Theragun will continue to be damaged by such infringement unless
10 enjoined by this Court. Theragun is entitled to recover damages adequate to
11 compensate for the infringement under 35 U.S.C. § 284.
12 114. Theragun is, and has been, irreparably harmed by Defendants’ on-going
13 infringement including the following harm which cannot be quantified or recouped
14 through monetary damages: (1) lost market share that will be difficult, if not
15 impossible, to recoup later as the Infringing Devices become entrenched with retail
16 sellers and trainers who recommend them to their clients, (2) loss of first mover
17 advantage that Theragun enjoyed as the first company to offer its innovative
18 percussive devices and patented attachments, (3) loss of Theragun’s investment in
19 developing the market for percussive devices and its patented attachments,
20 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
21 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
22 Devices being sold at a price point lower than Theragun’s patented products,
23 (7) diversion of resources to defend against loss of market share caused by sales of
24 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
25 to offer for sale and sell infringing attachments that leads to additional irreparable
26 harm described above.
27
28
67894037v2 27
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 29 of 46 Page ID #:29
1 115. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 TENTH CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘986 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 116. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 117. At all times herein mentioned the ‘986 Patent was and is valid and fully
11 enforceable.
12 118. Defendants are offering percussive massage devices that infringe the
13 ‘986 Patent, including at least the CRG-05, as shown in Fig. 18, above. As shown
14 below, a side by side comparison of Theragun’s ‘986 Patent and Defendants’
15 Infringing Devices quickly reveals that the Infringing Devices appear substantially
16 the same as Theragun’s ‘986 Patent to an ordinary observer; the resemblance is such
17 as to deceive such an observer, inducing him or her to purchase one supposing it to
18 be the other:
19
20
21
22
23
24 ‘986 Patent CRG-05
25 119. By the acts complained of herein, the Dezhou Defendants have been and
26 are presently infringing the ‘986 Patent by actively and knowingly: (i) importing,
27 making, using, selling and/or offering to sell products incorporating the design of the
28 ‘986 Patent, including the above-identified devices; (ii) inducing others to infringe
67894037v2 28
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 30 of 46 Page ID #:30
1 the ‘986 Patent by inducing others to import, sell, offer for sale, and/or use products
2 incorporating the design of the ‘986 Patent, including the above-identified devices;
3 and/or (iii) contributing to the infringement of the ‘986 Patent.
4 120. Defendants’ infringe literally or under the doctrine of equivalents, or
5 both.
6 121. At no time has Theragun granted Defendants authorization, license, or
7 permission to utilize the design claimed in the ‘986 Patent.
8 122. Theragun has been damaged by Defendants’ acts of infringement of the
9 ‘986 Patent and Theragun will continue to be damaged by such infringement unless
10 enjoined by this Court. Theragun is entitled to recover damages adequate to
11 compensate for the infringement under 35 U.S.C. § 284.
12 123. Theragun is, and has been, irreparably harmed by Defendants’ on-going
13 infringement including the following harm which cannot be quantified or recouped
14 through monetary damages: (1) lost market share that will be difficult, if not
15 impossible, to recoup later as the Infringing Devices become entrenched with retail
16 sellers and trainers who recommend them to their clients, (2) loss of first mover
17 advantage that Theragun enjoyed as the first company to offer its innovative
18 percussive devices and patented attachments, (3) loss of Theragun’s investment in
19 developing the market for percussive devices and its patented attachments,
20 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
21 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
22 Devices being sold at a price point lower than Theragun’s patented products,
23 (7) diversion of resources to defend against loss of market share caused by sales of
24 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
25 to offer for sale and sell infringing attachments that leads to additional irreparable
26 harm described above.
27
28
67894037v2 29
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 31 of 46 Page ID #:31
1 124. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘387 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 125. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 126. At all times herein mentioned the ‘387 Patent was and is valid and fully
11 enforceable.
12 127. Defendants include an infringing battery with one or more of their
13 Infringing Devices, including, at least the CRG-05 and the CRG-01, as shown in Figs.
14 18 & 20, above. As shown below, a side by side comparison of Theragun’s ‘387
15 Patent and Defendants’ infringing battery quickly reveals that the infringing
16 attachment appears substantially the same as Theragun’s ‘387 Patent to an ordinary
17 observer; the resemblance is such as to deceive such an observer, inducing him or her
18 to purchase one supposing it to be the other:
19
20
21
22
23 ‘387 Patent
24 Infringing Battery
25 128. By the acts complained of herein, the Dezhou Defendants have been and
26 are presently infringing the ‘387 Patent by actively and knowingly: (i) importing,
27 making, using, selling and/or offering to sell products incorporating the design of the
28 ‘387 Patent, including the above-identified battery; (ii) inducing others to infringe the
67894037v2 30
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 32 of 46 Page ID #:32
1 ‘387 Patent by inducing others to import, sell, offer for sale, and/or use products
2 incorporating the design of the ‘387 Patent, including the above-identified battery;
3 and/or (iii) contributing to the infringement of the ‘387 Patent.
4 129. Defendants’ infringe literally or under the doctrine of equivalents, or
5 both.
6 130. At no time has Theragun granted Defendants authorization, license, or
7 permission to utilize the design claimed in the ‘387 Patent.
8 131. Theragun has been damaged by Defendants’ acts of infringement of the
9 ‘387 Patent and Theragun will continue to be damaged by such infringement unless
10 enjoined by this Court. Theragun is entitled to recover damages adequate to
11 compensate for the infringement under 35 U.S.C. § 284.
12 132. Theragun is, and has been, irreparably harmed by Defendants’ on-going
13 infringement including the following harm which cannot be quantified or recouped
14 through monetary damages: (1) lost market share that will be difficult, if not
15 impossible, to recoup later as the Infringing Devices become entrenched with retail
16 sellers and trainers who recommend them to their clients, (2) loss of first mover
17 advantage that Theragun enjoyed as the first company to offer its innovative
18 percussive devices and patented attachments, (3) loss of Theragun’s investment in
19 developing the market for percussive devices and its patented attachments,
20 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
21 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
22 Devices being sold at a price point lower than Theragun’s patented products,
23 (7) diversion of resources to defend against loss of market share caused by sales of
24 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
25 to offer for sale and sell infringing attachments that leads to additional irreparable
26 harm described above.
27
28
67894037v2 31
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 33 of 46 Page ID #:33
1 133. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 TWELFTH CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘260 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 134. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 135. At all times herein mentioned the ‘260 Patent was and is valid and fully
11 enforceable.
12 136. Defendants include an infringing attachment with one or more of their
13 Infringing Devices, including, at least the CRG-05 and the CRG-04, as shown in Figs.
14 18 & 19, above. As shown below, a side by side comparison of Theragun’s ‘260
15 Patent and Defendants’ infringing attachment quickly reveals that the infringing
16 attachment appears substantially the same as Theragun’s ‘260 Patent to an ordinary
17 observer; the resemblance is such as to deceive such an observer, inducing him or her
18 to purchase one supposing it to be the other:
19
20
21
22
23 ‘260 Patent
Infringing Attachment
24
137. By the acts complained of herein, the Dezhou Defendants have been and
25
are presently infringing the ‘260 Patent by actively and knowingly: (i) importing,
26
making, using, selling and/or offering to sell products incorporating the design of the
27
‘260 Patent, including the above-identified attachment; (ii) inducing others to infringe
28
67894037v2 32
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 34 of 46 Page ID #:34
1 the ‘260 Patent by inducing others to import, sell, offer for sale, and/or use products
2 incorporating the design of the ‘260 Patent, including the above-identified
3 attachment; and/or (iii) contributing to the infringement of the ‘260 Patent.
4 138. Defendants’ infringe literally or under the doctrine of equivalents, or
5 both.
6 139. At no time has Theragun granted Defendants authorization, license, or
7 permission to utilize the design claimed in the ‘260 Patent.
8 140. Theragun has been damaged by Defendants’ acts of infringement of the
9 ‘260 Patent and Theragun will continue to be damaged by such infringement unless
10 enjoined by this Court. Theragun is entitled to recover damages adequate to
11 compensate for the infringement under 35 U.S.C. § 284.
12 141. Theragun is, and has been, irreparably harmed by Defendants’ on-going
13 infringement including the following harm which cannot be quantified or recouped
14 through monetary damages: (1) lost market share that will be difficult, if not
15 impossible, to recoup later as the Infringing Devices become entrenched with retail
16 sellers and trainers who recommend them to their clients, (2) loss of first mover
17 advantage that Theragun enjoyed as the first company to offer its innovative
18 percussive devices and patented attachments, (3) loss of Theragun’s investment in
19 developing the market for percussive devices and its patented attachments,
20 (4) negative effect on its reputation as innovator and pioneer, (5) the unquantifiable
21 effect on lost sales of related products, (6) price erosion due to Defendants’ Infringing
22 Devices being sold at a price point lower than Theragun’s patented products,
23 (7) diversion of resources to defend against loss of market share caused by sales of
24 the Infringing Devices, and (8) Defendants’ unauthorized sales that are enticing others
25 to offer for sale and sell infringing attachments that leads to additional irreparable
26 harm described above.
27
28
67894037v2 33
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 35 of 46 Page ID #:35
1 142. Defendants’ acts of infringement have been, and continue to be, willful
2 and deliberate and therefore warrant the award of attorneys’ fees pursuant to 35
3 U.S.C. § 285 and the award of enhanced damages pursuant to 35 U.S.C. § 284.
4 THIRTEENTH CAUSE OF ACTION
5 Patent Infringement, 35 U.S.C. §§ 101 et seq.
6 ‘261 Patent
7 (Against Dezhou and Does 1 through 10, inclusive)
8 143. Theragun realleges and incorporates by reference all foregoing
9 paragraphs as if fully set forth herein.
10 144. At all times herein mentioned the ‘261 Patent was and is valid and fully
11 enforceable.
12 145. Defendants include an infringing attachment with one or more of their
13 Infringing Devices, including, at least the CRG-03, as shown in Fig. 17, above. As
14 shown below, a side by side comparison of Theragun’s ‘261 Patent and Defendants’
15 infringing attachment quickly reveals that the infringing attachment appears
16 substantially the same as Theragun’s ‘261 Patent to an ordinary observer; the
17 resemblance is such as to deceive such an observer, inducing him or her to purchase
18 one supposing it to be the other:
19
20
21
22
23 ‘261 Patent Infringing Attachment
24 146. By the acts complained of herein, the Dezhou Defendants have been and
25 are presently infringing the ‘261 Patent by actively and knowingly: (i) importing,
26 making, using, selling and/or offering to sell products incorporating the design of the
27 ‘261 Patent, including the above-identified attachment; (ii) inducing others to infringe
28 the ‘261 Patent by inducing others to import, sell, offer for sale, and/or use products
67894037v2 34
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 36 of 46 Page ID #:36
67894037v2 35
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 37 of 46 Page ID #:37
67894037v2 36
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 38 of 46 Page ID #:38
67894037v2 37
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 39 of 46 Page ID #:39
67894037v2 38
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 40 of 46 Page ID #:40
67894037v2 39
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 41 of 46 Page ID #:41
67894037v2 40
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 42 of 46 Page ID #:42
67894037v2 41
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 43 of 46 Page ID #:43
67894037v2 42
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 44 of 46 Page ID #:44
1 similar thereto, including the Infringing Trade Dress, or engaging in further acts of
2 unfair competition or trademark or trade dress infringement;
3 D. For an order finding that the Patents, and each of them, are valid and
4 enforceable;
5 E. For an order finding that Defendants have infringed the Patents directly,
6 contributorily, and/or by inducement, literally or by equivalents, in violation of 35
7 U.S.C. § 271;
8 F. For an order temporarily, preliminarily and permanently enjoining
9 Defendants, their officers, directors, agents, servants, affiliates, employees,
10 subsidiaries, divisions, branches, parents, attorneys, representatives, privies, and all
11 others acting in concert or participation with any of them, from infringing the Patents
12 directly, contributorily and/or by inducement, or otherwise engaging in acts of unfair
13 competition;
14 G. For a judgment directing that any products in the possession, custody or
15 control of Defendants which infringe the Patents, the THERAGUN mark, and/or the
16 Trade Dress be delivered up and destroyed within 30 days of entry of judgment;
17 H. For a judgment directing Defendants to recall all such infringing
18 products and any other materials sold, distributed, advertised or marketed which
19 infringe the Patents, the THERAGUN mark, and/or the Trade Dress;
20 I. For an order directing Defendants to file with the Court, and serve upon
21 Theragun’s counsel, within thirty (30) days after entry of the order of injunction, a
22 report setting forth the manner and form in which each of them has complied with the
23 injunction;
24 J. For an order that, by the acts complained of herein, Defendants have
25 infringed Theragun’s common law trademark and trade dress rights and/or engaged
26 in acts of common law unfair competition against Theragun;
27 K. For an order finding that Defendants’ conduct alleged herein was willful
28 and intentional and in conscious disregard of Theragun’s rights;
67894037v2 43
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 45 of 46 Page ID #:45
67894037v2 44
COMPLAINT
Case 2:20-cv-03821 Document 1 Filed 04/27/20 Page 46 of 46 Page ID #:46
67894037v2 45
COMPLAINT
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 1 of 9 Page ID #:47
EXHIBIT A
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 2 of 9 Page ID #:48
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 3 of 9 Page ID #:49
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 4 of 9 Page ID #:50
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 5 of 9 Page ID #:51
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 6 of 9 Page ID #:52
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 7 of 9 Page ID #:53
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 8 of 9 Page ID #:54
Case 2:20-cv-03821 Document 1-1 Filed 04/27/20 Page 9 of 9 Page ID #:55
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 1 of 8 Page ID #:56
EXHIBIT B
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 2 of 8 Page ID #:57
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 3 of 8 Page ID #:58
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 4 of 8 Page ID #:59
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 5 of 8 Page ID #:60
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 6 of 8 Page ID #:61
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 7 of 8 Page ID #:62
Case 2:20-cv-03821 Document 1-2 Filed 04/27/20 Page 8 of 8 Page ID #:63
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 1 of 8 Page ID #:64
EXHIBIT C
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 2 of 8 Page ID #:65
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 3 of 8 Page ID #:66
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 4 of 8 Page ID #:67
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 5 of 8 Page ID #:68
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 6 of 8 Page ID #:69
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 7 of 8 Page ID #:70
Case 2:20-cv-03821 Document 1-3 Filed 04/27/20 Page 8 of 8 Page ID #:71
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 1 of 9 Page ID #:72
EXHIBIT D
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 2 of 9 Page ID #:73
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 3 of 9 Page ID #:74
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 4 of 9 Page ID #:75
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 5 of 9 Page ID #:76
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 6 of 9 Page ID #:77
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 7 of 9 Page ID #:78
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 8 of 9 Page ID #:79
Case 2:20-cv-03821 Document 1-4 Filed 04/27/20 Page 9 of 9 Page ID #:80
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 1 of 8 Page ID #:81
EXHIBIT E
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 2 of 8 Page ID #:82
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 3 of 8 Page ID #:83
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 4 of 8 Page ID #:84
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 5 of 8 Page ID #:85
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 6 of 8 Page ID #:86
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 7 of 8 Page ID #:87
Case 2:20-cv-03821 Document 1-5 Filed 04/27/20 Page 8 of 8 Page ID #:88
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 1 of 8 Page ID #:89
EXHIBIT F
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 2 of 8 Page ID #:90
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 3 of 8 Page ID #:91
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 4 of 8 Page ID #:92
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 5 of 8 Page ID #:93
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 6 of 8 Page ID #:94
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 7 of 8 Page ID #:95
Case 2:20-cv-03821 Document 1-6 Filed 04/27/20 Page 8 of 8 Page ID #:96
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 1 of 9 Page ID #:97
EXHIBIT G
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 2 of 9 Page ID #:98
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 3 of 9 Page ID #:99
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 4 of 9 Page ID #:100
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 5 of 9 Page ID #:101
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 6 of 9 Page ID #:102
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 7 of 9 Page ID #:103
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 8 of 9 Page ID #:104
Case 2:20-cv-03821 Document 1-7 Filed 04/27/20 Page 9 of 9 Page ID #:105
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 1 of 12 Page ID #:106
EXHIBIT H
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 2 of 12 Page ID #:107
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 3 of 12 Page ID #:108
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 4 of 12 Page ID #:109
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 5 of 12 Page ID #:110
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 6 of 12 Page ID #:111
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 7 of 12 Page ID #:112
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 8 of 12 Page ID #:113
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 9 of 12 Page ID #:114
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 10 of 12 Page ID #:115
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 11 of 12 Page ID #:116
Case 2:20-cv-03821 Document 1-8 Filed 04/27/20 Page 12 of 12 Page ID #:117
Case 2:20-cv-03821 Document 1-9 Filed 04/27/20 Page 1 of 8 Page ID #:118
EXHIBIT I
Case 2:20-cv-03821 Document 1-9 Filed 04/27/20 Page 2 of 8 Page ID #:119
USOOD8492615
(12 ) United States Design Patent ( 10) Patent No.: US D849 ,261 S
Wersland et al. (45) Date of Patent: * * May 21, 2019
(54) MASSAGE ELEMENT D347 ,282 S *
D356 ,035 S *
5/ 1994 Yoo ............................. 124 /200
3 / 1995 Kim ............. .. D9 /454
(71) Applicant: THERAGUN , LLC , Beverly Hills, CA 5 ,470, 303 A * 11/ 1995 Leonard ........... ...... A61H 19 / 34
600/ 38
(US ) D417 ,008 S * 11/ 1999 Chien ......... ... D24 /211
7, 306 ,570 B1 * 12 /2007 Julian ............... .... A61H 7 /007
(72 ) Inventors : Jason Wersland ,Manhattan Beach , CA 601/ 134
(US) ; Michael Waldron , Dunnington D639 ,430 S * 6 / 2011 Yoo .. D24 / 146
(GB); Geert Ensing, Shanghai (CN ) D639 ,431 S * 6 / 2011 Yoo D24 / 146
(Continued )
(73) Assignee: THERAGUN , LLC , Beverly Hills, CA
(US ) OTHER PUBLICATIONS
(* * ) Term : 15 Years Theragun , “ Cone AmpBITs ” , Feb . 2 , 2018 . https ://theragun .com
collections/the - g2pro -accessories/ products/the -cone -ampbit-3 -pack
(21) Appl. No.: 29/637,060 for-g2pro . Shown on p . 1. ( Year: 2018 ). *
( 22 ) Filed : Feb . 13 , 2018 Primary Examiner — Cynthia Ramirez
Assistant Examiner — Michael A Maharajh
Related U .S. Application Data (74 ) Attorney, Agent, or Firm — Jeffer Mangels Butler &
(63) Continuation - in -part of application No. 15 /647 ,050 , Mitchell LLP; Brennan C . Swain , Esq .
filed on Jul. 11, 2017 . CLAIM
(51) LOC (11) CI. 28 -03 (57)
(52 ) U . S . CI. The ornamental design for a massage element,as shown and
USPC . ... ... ... .. . ............... D24 /211 described .
(58) Field of Classification Search DESCRIPTION
USPC ..... 52 / 574 ; 273/ 153 P, 153 R , 153 S , 157 R ,
273 / 160 ; 434 /211 , 259 ; 600 /38 ; 601 /15 , FIG . 1 is a perspective view of the present invention ;
601/ 18 , 19 , 27 , 28 , 29 , 30 , 31 , 32, 46 , 47, FIG . 2 is a front elevational view of the present invention
601/48 , 52, 72 , 99, 112 , 113 , 118 , 135 , shown in FIG . 1 , the rear, right and left side elevational
601/137 , DIG . 12 , DIG . 14 , DIG . 15 , views being mirror images thereof;
601 /DIG . 16 , DIG . 17 ; D21/ 505 ; FIG . 3 is a top plan view of the present invention shown in
D24 /200 , 211 , 212 , 213 , 214 , 215 ; FIG . 1 ;
D9/434 , 443 , 454 FIG . 4 is a bottom plan view of the present invention shown
CPC A61H 15 /00 ; A61H 2015 /0014 in FIG . 1 ; and ,
See application file for complete search history. FIG . 5 is a front elevational view of the present invention
(56 ) shown in FIG . 2 with a portion shown in cross- section .
References Cited The broken lines in the figures are for the purpose of
U .S . PATENT DOCUMENTS illustrating portions of the massage element that form no
part of the claimed design .
D192,758 S * 5 / 1962 Rijnovan ....................... D9/443
D197 , 192 S * 12/ 1963 Lorenzen ...................... D9 /443 1 Claim , 5 Drawing Sheets
-
-
-
Case 2:20-cv-03821 Document 1-9 Filed 04/27/20 Page 3 of 8 Page ID #:120
US D849 ,261 S
Page 2
FIG . 1
Case 2:20-cv-03821 Document 1-9 Filed 04/27/20 Page 5 of 8 Page ID #:122
RRRRR .
FIG . 2
Case 2:20-cv-03821 Document 1-9 Filed 04/27/20 Page 6 of 8 Page ID #:123
-
-
-
E
-
-
-
-
FIG . 3
Case 2:20-cv-03821 Document 1-9 Filed 04/27/20 Page 7 of 8 Page ID #:124
-
-
---
-
-
.
.
.her
*
**
**
--
.
.
FIG . 4
Case 2:20-cv-03821 Document 1-9 Filed 04/27/20 Page 8 of 8 Page ID #:125
EEEEEEEEEEEEEEEEE
kiniiiiiii
- -- -- -- - - - - -- - - -- - - - - -- -- - - .
-
.
FIG . 5
Case 2:20-cv-03821 Document 1-10 Filed 04/27/20 Page 1 of 7 Page ID #:126
EXHIBIT J
Case 2:20-cv-03821 Document 1-10 Filed 04/27/20 Page 2 of 7 Page ID #:127
USOOD8611825
!
TI
Hi
-
Case 2:20-cv-03821 Document 1-10 Filed 04/27/20 Page 3 of 7 Page ID #:128
US D861 ,182 S
Page 2
FIG . 1
Case 2:20-cv-03821 Document 1-10 Filed 04/27/20 Page 5 of 7 Page ID #:130
-
--
FIG . 2
www .- -
Case 2:20-cv-03821 Document 1-10 Filed 04/27/20 Page 6 of 7 Page ID #:131
!! ! ill
i - i- i - i- i - i- i
ho
FIG . 3
Case 2:20-cv-03821 Document 1-10 Filed 04/27/20 Page 7 of 7 Page ID #:132
-
-
-
-
--------
--
-----
-------
FIG . 4
Case 2:20-cv-03821 Document 1-11 Filed 04/27/20 Page 1 of 8 Page ID #:133
EXHIBIT K
Case 2:20-cv-03821 Document 1-11 Filed 04/27/20 Page 2 of 8 Page ID #:134
USOOD850640S
(12 ) United States Design Patent ( 10) Patent No.: US D850 ,640 S
Wersland et al. (45) Date of Patent: * * Jun . 4 , 2019
(54) MASSAGE ELEMENT D376 ,015 S * 11/ 1996 Newberry .................... D24 /211
5 ,577, 996 A * 11/ 1996 Gardner ............. A61H 15 /0092
(71) Applicant: THERAGUN , LLC , Beverly Hills, CA D387, 871 S * 12 /1997 Childs ....
601/ 118
D24 /211
(US ) D389,409 S * 1/1998 Tucker .. .. ..
. ............ D9/454
5,765,921 A * 6 / 1998 Chuang ............... A47C 16 /025
(72 ) Inventors : Jason Wersland ,Manhattan Beach , CA 601/ 118
(US) ; Michael Waldron , Dunnington D396 ,110 S * 7 / 1998 Kang D24 /211
(GB); Geert Ensing, Shanghai (CN ) D403 ,076 S * 12 / 1998 York
D403 ,428 S * 12 /1998 Russo
D24 /214
.... ..... . D24 /200
(73) Assignee: THERAGUN , LLC , Beverly Hills, CA (Continued )
(US )
OTHER PUBLICATIONS
(* * ) Term : 15 Years
Theragun, “ Standard Ball AmpBITs” , Feb . 1, 2018. https://theragun.
(21) Appl.No.: 29/637,057 com /collections/the - g2pro -accessories/products/ampbit -attachment
the -standard -ball -3 -pack . Shown on p . 1 . (Year: 2018 ). *
( 22 ) Filed : Feb . 13 , 2018
Primary Examiner - Cynthia Ramirez
Related U .S . Application Data Assistant Examiner — Michael A Maharajh
(63 ) Continuation -in -part of application No. 15 /647,050 , ( 74 ) Attorney, Agent, or Firm — Jeffer Mangels Butler &
filed on Jul. 11 , 2017 . Mitchell LLP ; Brennan C . Swain
(51) LOC (11) CI. .... ..... 28 -03 (57) CLAIM
(52 ) U . S . CI. The ornamental design for a massage element, as shown and
USPC . ... ... ... ... .......... D24 /211 described .
Field of Classification Search
USPC ..... 52/ 574 ; 273/ 153 P . 153 R , 153 S , 157 R , DESCRIPTION
273 / 160 ; 434 / 211 , 259 ; 600 / 38 ; 601/ 15 ,
601 / 18 , 19 , 27 , 28 , 29 , 30 , 31 , 32 , 46 , 47 , FIG . 1 is a perspective view of the present invention ;
601/48, 52 , 72, 99 , 112 , 113, 118 , 135 , FIG . 2 is a front elevational view of the present invention
601 / 137, DIG . 12 , DIG . 14 , DIG . 15 , shown in FIG . 1 , the rear , right and left side elevational
601/DIG . 16 , DIG . 17 ; D21/ 505 ; views being mirror images thereof;
D24 /200 , 211 , 212 , 213 , 214 , 215 ; FIG . 3 is a top plan view of the present invention shown in
D9/ 434, 443 , 454 FIG . 1 ;
CPC ....... ...... A61H 15 /00 ; A61H 2015 /0014 FIG . 4 is a bottom plan view of the present invention shown
See application file for complete search history . in FIG . 1 ; and ,
FIG . 5 is a front elevational view of the present invention
(56 ) References Cited shown in FIG . 2 with a portion shown in cross - section .
The broken lines in the figures are for the purpose of
U .S. PATENT DOCUMENTS illustrating portions of the massage element that form no
2 ,854 ,971 A * 10 /1958 Williams .............. A61H 15 /00 part of the claimed design .
606 / 238
D311,790 S * 10 / 1990 Krief .......... D10 /68 1 Claim , 5 Drawing Sheets
-
"
- - - -- -- -. .
--- - - -- - - --
Case 2:20-cv-03821 Document 1-11 Filed 04/27/20 Page 3 of 8 Page ID #:135
US D850 ,640 S
Page 2
them
-- - - - - - - - - - - - - - -
FIG . 1
Case 2:20-cv-03821 Document 1-11 Filed 04/27/20 Page 5 of 8 Page ID #:137
5
yowekw wanawake
**
*
*
generationwarnis
-----
-
---
-
**
*
-
-
-
-
-
-
-
-
*
*
*
*
***
-**-
---
.
www
- - -- - - -- ---
- - -
FIG . 2
Case 2:20-cv-03821 Document 1-11 Filed 04/27/20 Page 6 of 8 Page ID #:138
-
-
--
-
-
-
--
-
-.
..
..
.
..
.
.
www
-
-
-
-
-
-
-
-
- - - - - - - - - - -
- - - - - - - - - - - - - - --- -
FIG . 3
Case 2:20-cv-03821 Document 1-11 Filed 04/27/20 Page 7 of 8 Page ID #:139
- -
-
-
--
-
.. .
- ....
-
**--
FIG . 4
Case 2:20-cv-03821 Document 1-11 Filed 04/27/20 Page 8 of 8 Page ID #:140
YYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
w testi tit it ti ti ti tu
-
-
-
+
-
+
*
*
*
*
**
**
**
**
*
*
- - - - -- - - - - --
- -- - - -
FIG . 5
Case 2:20-cv-03821 Document 1-12 Filed 04/27/20 Page 1 of 7 Page ID #:141
EXHIBIT L
Case 2:20-cv-03821 Document 1-12 Filed 04/27/20 Page 2 of 7 Page ID #:142
USOOD859680S
601/ 134
(73 ) Assignee: THERAGUN , LLC , Santa Monica, CA D270 ,279 S *
D274 ,555 S *
*
*
8 / 1983 Hamilton .... .... ............ D24 /211
7 /1984 Shiu .................. D24 /211
(US ) D311,790 S * 10 / 1990 Krief
*
- - - - - - - -
-- - - . . .- - -
.. . . - . - . -.- .
Case 2:20-cv-03821 Document 1-12 Filed 04/27/20 Page 3 of 7 Page ID #:143
US D859 ,680 S
Page 2
- -- -
-
-
---
- .
.
..***
*
-
-
st.-
-
FIG . 1
Case 2:20-cv-03821 Document 1-12 Filed 04/27/20 Page 5 of 7 Page ID #:145
?????????????????
Whetr
-
-
--
-
---
-
--
----
-
-*
**
*
*
*
**
**
*
***
**
**
--
wii
.
-
-
-
--
. - . . - .- . - .- . -. - .
- - -- - - - - - - - - -- - -
NR.
FIG . 2
Case 2:20-cv-03821 Document 1-12 Filed 04/27/20 Page 6 of 7 Page ID #:146
( w
-
-
-
-
-
.
+ .
.
-
-
+ -
-
-
-
-
+
-
w
-
-
- --
---
---
**** **----
-- - - - - -
FIG . 3
Case 2:20-cv-03821 Document 1-12 Filed 04/27/20 Page 7 of 7 Page ID #:147
NY
-
-
-
*
*
*
*
*
**
**
*
*
-
-
- - - -- - - - - - . . . - - - -- -
FIG . 4